ACE and heart failure: Moreover, in line with our findings, a recent pilot study including 34 patients with arterial hypertension or heart failure treatment with an ACE inhibitor (ramipril) demonstrated significantly increased SFLLRN-inducible platelet reactivity already 4 h after treatment initiation, which remained elevated during therapy [15].